1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid

C49H58N14O12S — CID 164587851

IUPAC1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid
SMILESCCn1nc(C)cc1C(=O)Nc1nc2cc(C(=O)O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN(C)C(=O)CCN3C(=O)CC(SCC(N)C(=O)O)C3=O)c21
InChIInChI=1S/C49H58N14O12S/c1-7-62-33(18-26(3)56-62)43(67)54-48-53-32-21-29(46(70)71)23-35(74-6)40(32)60(48)14-9-10-15-61-41-31(52-49(61)55-44(68)34-19-27(4)57-63(34)8-2)20-28(42(51)66)22-36(41)75-17-11-13-58(5)38(64)12-16-59-39(65)24-37(45(59)69)76-25-30(50)47(72)73/h9-10,18-23,30,37H,7-8,11-17,24-25,50H2,1-6H3,(H2,51,66)(H,70,71)(H,72,73)(H,52,55,68)(H,53,54,67)/b10-9+
InChIKeyDJUGTLYHONAKAR-MDZDMXLPSA-N
MW1067.16 g/mol
LogP2.89
Rot. Bonds25

About 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid

1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid (PubChem CID 164587851) has the molecular formula C49H58N14O12S and a molecular weight of 1067.16 g/mol. Its IUPAC name is 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid.

Molecular Properties

Compound Name1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid
PubChem CID164587851
Molecular FormulaC49H58N14O12S
Molecular Weight1067.16 g/mol
Exact Mass1066.41
IUPAC Name1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid
SMILESCCn1nc(C)cc1C(=O)Nc1nc2cc(C(=O)O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN(C)C(=O)CCN3C(=O)CC(SCC(N)C(=O)O)C3=O)c21
InChIInChI=1S/C49H58N14O12S/c1-7-62-33(18-26(3)56-62)43(67)54-48-53-32-21-29(46(70)71)23-35(74-6)40(32)60(48)14-9-10-15-61-41-31(52-49(61)55-44(68)34-19-27(4)57-63(34)8-2)20-28(42(51)66)22-36(41)75-17-11-13-58(5)38(64)12-16-59-39(65)24-37(45(59)69)76-25-30(50)47(72)73/h9-10,18-23,30,37H,7-8,11-17,24-25,50H2,1-6H3,(H2,51,66)(H,70,71)(H,72,73)(H,52,55,68)(H,53,54,67)/b10-9+
InChIKeyDJUGTLYHONAKAR-MDZDMXLPSA-N
XLogP2.89
TPSA349.34 Ų
H-Bond Donors6
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms76
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001067.16
LogP ≤ 52.89
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid?
The IUPAC name of 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid (CID 164587851) is 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid.
What is the SMILES notation for 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid?
The canonical SMILES for 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid is CCn1nc(C)cc1C(=O)Nc1nc2cc(C(=O)O)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN(C)C(=O)CCN3C(=O)CC(SCC(N)C(=O)O)C3=O)c21.
What is the InChIKey of 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid?
The InChIKey is DJUGTLYHONAKAR-MDZDMXLPSA-N. The full InChI is InChI=1S/C49H58N14O12S/c1-7-62-33(18-26(3)56-62)43(67)54-48-53-32-21-29(46(70)71)23-35(74-6)40(32)60(48)14-9-10-15-61-41-31(52-49(61)55-44(68)34-19-27(4)57-63(34)8-2)20-28(42(51)66)22-36(41)75-17-11-13-58(5)38(64)12-16-59-39(65)24-37(45(59)69)76-25-30(50)47(72)73/h9-10,18-23,30,37H,7-8,11-17,24-25,50H2,1-6H3,(H2,51,66)(H,70,71)(H,72,73)(H,52,55,68)(H,53,54,67)/b10-9+.
What are the key properties of 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid?
1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid has a molecular weight of 1067.16 g/mol, XLogP of 2.89, 25 rotatable bonds, 6 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(E)-4-[7-[3-[3-[3-(2-amino-2-carboxyethyl)sulfanyl-2,5-dioxopyrrolidin-1-yl]propanoyl-methylamino]propoxy]-5-carbamoyl-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]benzimidazol-1-yl]but-2-enyl]-2-[(2-ethyl-5-methylpyrazole-3-carbonyl)amino]-7-methoxybenzimidazole-5-carboxylic acid is sourced from PubChem (CID 164587851), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).